SCHEMBL29695589

CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)CN)C(C)C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 15)

	gene	UniProt	supporting neighbours	confidence
▸	TFPI	P10646	1/20	0.50

▸	VIPR1	P32241	3/20	0.45

▸	GLP1R	P43220	1/20	0.44

▸	GCGR	P47871	1/20	0.44

▸	GIPR	P48546	1/20	0.44

▸	IL23R	Q5VWK5	2/20	0.43

▸	VIPR2	P41587	4/20	0.43

▸	RXFP1	Q9HBX9	2/20	0.42

▸	GRIN2D	O15399	1/20	0.42

▸	GRIN3B	O60391	1/20	0.42

▸	GRIN1	Q05586	1/20	0.42

▸	GRIN2A	Q12879	1/20	0.42

▸	GRIN2B	Q13224	1/20	0.42

▸	GRIN2C	Q14957	1/20	0.42

▸	GRIN3A	Q8TCU5	1/20	0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29856153	0.91	TFPI (0.47)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL30432333	0.91	TFPI (0.58)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL29489379	0.88	GRIN2D (0.55)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL30564496	0.86	NPY4R (0.49)	TFPI
SCHEMBL30432423	0.85	TFPI (0.61)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL29473680	0.84	TFPI (0.51)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL29593786	0.84	VIPR1 (0.48)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL31195329	0.84	VIPR1 (0.44)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL31462925	0.84	VIPR1 (0.51)	TFPIVIPR1GLP1RGCGRGIPR
SCHEMBL31670624	0.84	TFPI (0.49)	TFPIIL23RRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4267193-A1	IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF	Ludwig-Maximilians-Universität München (DE)	2023-11-01	—	—	EP	disclosed
WO-2022136555-A1	IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF	LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE)	2022-06-30	—	—	WO	disclosed